| 1 | 1 ml reconstituted solution contains 5 mg rabbit, anti-human thymocyte immunoglobulin. | [1] Rabbit Rabbit | - | - | - | [1] 60 60 💬
|
| 2 | 10% intravenous immunoglobulin (IVIg) | - | - | - | - | [1] 14 14 💬
|
| 3 | 10% liquid formulation of human immunoglobulin | - | - | - | - | [1] 14 14 💬
|
| 4 | : immunoglobulina umana normale 10% per somministrazione endovenosa | - | - | - | - | [1] 14 14 💬
|
| 5 | [Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma | - | - | - | - | [2] 96 96, 97 💬
|
| 6 | Also referred to as 'MEDI2070'Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 240-Product Name: BrazikumabProduct Code: MEDI2070Pharmaceutical Form: Solution for injection/infusionINN or Proposed INN: BRAZIKUMABCAS Number: 1610353-18-8Other descriptive name: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | [1] 97 97 💬
|
| 7 | Anti-(human tumor necrosis factor) immunoglobulin G (human-mouse monoclonal cA2 heavy chain) | - | - | - | - | [1] 271 271 💬
|
| 8 | Anti-human immunoglobulin, equine | - | - | - | - | [1] 60 60 💬
|
| 9 | Anti-human T-lymphocyte immunoglobulin from horse | - | - | - | - | [1] 60 60 💬
|
| 10 | ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN FROM RABBITS | - | - | - | - | [1] 51 51 💬
|
| 11 | Anti-human thymocyte immunoglobulin, equine | - | - | - | - | [1] 60 60 💬
|
| 12 | Anti-Human Thymocyte Immunoglobulin, Rabbit | [1] Rabbit Rabbit | - | - | - | [1] 60 60 💬
|
| 13 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human | - | - | - | - | [2] 96 96, 97 💬
|
| 14 | Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | [2] 96 96, 97 💬
|
| 15 | Anticorpo monoclonale umano anti-Interleuchina-23 Immunoglobulina G2 (IgG2) | - | - | - | - | [1] 96 96 💬
|
| 16 | ANTITHYMOCYTE IMMUNOGLOBULIN | - | - | - | - | [1] 13 13 💬
|
| 17 | Antithymocyte immunoglobulin (rabbit) | [1] Rabbit Rabbit | - | - | - | [2] 13 13, 96 💬
|
| 18 | Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL) | - | - | - | - | [1] 14 14 💬
|
| 19 | Biological: Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL) | - | - | - | - | [1] 14 14 💬
|
| 20 | Blood samples for immunoglobulins | - | - | - | - | [1] 28 28 💬
|
| 21 | BrazikumabProduct Code: MEDI2070Pharmaceutical Form: Solution for injection/infusion in pre-filled syringeINN or Proposed INN: BRAZIKUMABCAS Number: 1610353-18-8Other descriptive name: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody | - | - | - | - | [1] 97 97 💬
|
| 22 | Corticosteroids combined with immunoglobulin and romiplostim | [1] Romiplostim Romiplostim | [1] Romiplostim
Romiplostim
💬
| [1] MPL MPL 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | [1] 63 63 💬
|
| 23 | Cyclin D1 gene (CCDN1) /immunoglobulin heavy chain (IGH) fluorescence in situ hybridization (FISH) assay | - | - | - | - | [1] 28 28 💬
|
| 24 | Denosumab - - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand | [1] Denosumab Denosumab | [1] Denosumab
Denosumab
💬
| [1] TNFSF11 TNFSF11 💬
| [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [1] 274 274 💬
|
| 25 | Denosumab - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand | [1] Denosumab Denosumab | [1] Denosumab
Denosumab
💬
| [1] TNFSF11 TNFSF11 💬
| [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [1] 274 274 💬
|
| 26 | Diagnostic Test: 4 ml. of fresh venous blood will be collected from each patient on EDTA tube and will be used for detection of the following : T cell immunoglobulin G ( TIgG) and T cell immunoglobulin M (TIgM) by | - | - | - | - | [1] 49 49 💬
|
| 27 | Diagnostic Test: A. Routine .1CBC with blood film. .2Liver Function Test. .3Kidney Function Test. 4. Inflamatory marker ESR, CRP B.Immunology 1-Immunoglobulins IgG, IgM, IgA, IgE 2-Flow cytometric assessment: B | - | - | - | - | [1] 65 65 💬
|
| 28 | Gammaplex (Intravenous immunoglobulin) | - | - | - | - | [1] 65 65 💬
|
| 29 | Gammaplex, intravenous immunoglobulin | - | - | - | - | [1] 63 63 💬
|
| 30 | GB-0998 (Intravenous immunoglobulin) | - | - | - | - | [1] 11 11 💬
|
| 31 | High-dose intravenous immunoglobulin (IVIG) | - | - | - | - | [1] 18 18 💬
|
| 32 | High-dose intravenous immunoglobulin (Venoglobulin-IH) | - | - | - | - | [1] 51 51 💬
|
| 33 | Himan Normal Immunoglobulin | - | - | - | - | [1] 14 14 💬
|
| 34 | Human Immunoglobulin | - | - | - | - | [2] 63 63, 65 💬
|
| 35 | Human immunoglobulin (pH4) for intravenous injection | - | - | - | - | [1] 63 63 💬
|
| 36 | HUMAN IMMUNOGLOBULIN G | [1] Human immunoglobulin G Human immunoglobulin G (Human immunoglobulin) | [1] Globulin, immune
Globulin, immune
(Human normal immunoglobulin) 💬
| - | - | [4] 14 14, 50, 63, 65 💬
|
| 37 | Human immunoglobulin intravenous | - | - | - | - | [1] 63 63 💬
|
| 38 | Human normal 10% immunoglobulin for intravenous administration | - | - | - | - | [1] 14 14 💬
|
| 39 | Human normal 10% immunoglobulin for intravenous administrationn | - | - | - | - | [1] 14 14 💬
|
| 40 | Human normal immunoglobulin | - | - | - | - | [6] 13 13, 14, 50, 51, 63, 65 💬
|
| 41 | HUMAN NORMAL IMMUNOGLOBULIN (IV) | - | - | - | - | [4] 11 11, 14, 63, 65 💬
|
| 42 | Human normal immunoglobulin (IVIg) | - | - | - | - | [3] 14 14, 50, 65 💬
|
| 43 | Human normal immunoglobulin (SCIg) | - | - | - | - | [1] 14 14 💬
|
| 44 | Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin) | - | - | - | - | [1] 65 65 💬
|
| 45 | Human normal immunoglobulin (subcutaneous) | - | - | - | - | [1] 65 65 💬
|
| 46 | HUMAN NORMAL IMMUNOGLOBULIN FOR | - | - | - | - | [1] 65 65 💬
|
| 47 | Human normal immunoglobulin for intravenous (IV) administration | - | - | - | - | [1] 51 51 💬
|
| 48 | Human normal immunoglobulin for intravenous administration | - | - | - | - | [3] 14 14, 51, 65 💬
|
| 49 | HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE | - | - | - | - | [2] 63 63, 65 💬
|
| 50 | Human normal immunoglobulin for intravenous use (IVIG) | - | - | - | - | [1] 65 65 💬
|
| 51 | HUMAN NORMAL IMMUNOGLOBULIN FOR INTRVENOUS USE | - | - | - | - | [1] 63 63 💬
|
| 52 | Human normal immunoglobulin for subcutaneous administration | - | - | - | - | [2] 51 51, 65 💬
|
| 53 | Human Normal Immunoglobulin for Subcutaneous Administration (IGSC) | - | - | - | - | [1] 65 65 💬
|
| 54 | Human normal immunoglobulin G (IgG > 98% purity) | - | - | - | - | [3] 14 14, 63, 65 💬
|
| 55 | Human normal immunoglobulin G (IgG) | - | - | - | - | [1] 11 11 💬
|
| 56 | Humanized immunoglobulin gamma 1 (IgG1) kappa monoclonal antibody | - | - | - | - | [1] 46 46 💬
|
| 57 | Hypersialylated immunoglobulin | - | - | - | - | [1] 63 63 💬
|
| 58 | I.v. immunoglobulins | - | - | - | - | [1] 151 151 💬
|
| 59 | Immunoglobulin | - | - | - | - | [3] 13 13, 14, 63 💬
|
| 60 | Immunoglobulin (Hizentra) | - | - | - | - | [1] 50 50 💬
|
| 61 | IMMUNOGLOBULIN G | - | - | - | - | [9] 2 2, 11, 13, 14, 36, 49, 50, 63, 65 💬
|
| 62 | Immunoglobulin G (Ig NextGen 16%) | - | - | - | - | [1] 65 65 💬
|
| 63 | Immunoglobulin G cleaving cystein protease derived from E. coli | - | - | - | - | [2] 43 43, 44 💬
|
| 64 | Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy | - | - | - | - | [1] 2 2 💬
|
| 65 | Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy chain), disulfide with human Mus musculus monoclonal light chain, dimer | - | - | - | - | [1] 2 2 💬
|
| 66 | Immunoglobulin G1, anti-(human type I interferon receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546-chain, dimer | - | - | - | - | [1] 49 49 💬
|
| 67 | Immunoglobulin Intravenous (Human) | - | - | - | - | [2] 63 63, 65 💬
|
| 68 | Immunoglobulin IV | - | - | - | - | [1] 222 222 💬
|
| 69 | Immunoglobulin perfusion | - | - | - | - | [1] 14 14 💬
|
| 70 | IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI | - | - | - | - | [1] 51 51 💬
|
| 71 | Immunoglobulina normale umana | - | - | - | - | [2] 14 14, 51 💬
|
| 72 | Immunoglobulina Normale Umana per somministrazione endovenosa | - | - | - | - | [1] 51 51 💬
|
| 73 | Immunoglobulina Normale Umana per somministrazione sottocutanea | - | - | - | - | [1] 51 51 💬
|
| 74 | IMMUNOGLOBULINA UMANA NORMALE | - | - | - | - | [4] 14 14, 51, 63, 65 💬
|
| 75 | IMMUNOGLOBULINA UMANA NORMALE per somministrazione endovenosa | - | - | - | - | [1] 14 14 💬
|
| 76 | Immunoglobuline G | - | - | - | - | [1] 14 14 💬
|
| 77 | Immunoglobuline humaine normale | - | - | - | - | [1] 14 14 💬
|
| 78 | Immunoglobulines humaines normales | - | - | - | - | [1] 222 222 💬
|
| 79 | Immunoglobulins | - | - | - | - | [1] 14 14 💬
|
| 80 | Immunoglobulins Intravenous (Human) | - | - | - | - | [1] 65 65 💬
|
| 81 | Immunoglobulins, normal human | - | - | - | - | [1] 65 65 💬
|
| 82 | Immunoglobulins, normal human, for extravascular adm. | - | - | - | - | [1] 14 14 💬
|
| 83 | Immunoglobulins, normal human, for intravascular adm. | - | - | - | - | [2] 14 14, 15 💬
|
| 84 | Intravenous Immunoglobulin | - | - | - | - | [9] 13 13, 14, 35, 38, 39, 49, 51, 63, 309 💬
|
| 85 | Intravenous immunoglobulin (IVIg) | - | - | - | - | [8] 14 14, 17, 19, 63, 65, 85, 164, 296 💬
|
| 86 | Intravenous immunoglobulin (IVIG), 10% solution for infusion | - | - | - | - | [2] 2 2, 63 💬
|
| 87 | Intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG) | - | - | - | - | [1] 11 11 💬
|
| 88 | Intravenous immunoglobulin infusion | - | - | - | - | [1] 65 65 💬
|
| 89 | Intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO) | [2] Recombinant Human Thrombopoietin Recombinant Human Thrombopoietin, Thrombopoietin | - | - | - | [1] 63 63 💬
|
| 90 | Intravenous immunoglobulins | - | - | - | - | [1] 63 63 💬
|
| 91 | Intravenous immunoglobulins (human immunoglobulins G) | - | - | - | - | [1] 43 43 💬
|
| 92 | IVIG (Intravenous Immunoglobulin) | - | - | - | - | [2] 11 11, 14 💬
|
| 93 | L04AA04 - IMMUNOGLOBULINA ANTITIMOCITARIA (DI CONIGLIO) IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI THYMOGLOBULINE | - | - | - | - | [1] 13 13 💬
|
| 94 | Normal human immunoglobulin G | [1] Human immunoglobulin G Human immunoglobulin G (Human immunoglobulin) | [1] Globulin, immune
Globulin, immune
(Human normal immunoglobulin) 💬
| - | - | [1] 65 65 💬
|
| 95 | One ml contains horse anti-human T lymphocyte immunoglobulin (eATG) 50 mg | - | - | - | - | [1] 60 60 💬
|
| 96 | Rabbit anti-human thymocyte immunoglobulin | [1] Rabbit Rabbit | - | - | - | [2] 13 13, 96 💬
|
| 97 | RABBIT HUMAN T LYMPHOCYTE IMMUNOGLOBULIN | [1] Rabbit Rabbit | - | - | - | [2] 13 13, 60 💬
|
| 98 | Serum bovine immunoglobulin | - | - | - | - | [2] 96 96, 97 💬
|
| 99 | Subcutaneous immunoglobulin | - | - | - | - | [1] 14 14 💬
|
| 100 | Subcutaneous immunoglobulin (SCIG) | - | - | - | - | [1] 11 11 💬
|
| 101 | Subcutaneous immunoglobulins | - | - | - | - | [1] 11 11 💬
|
| 102 | Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg) | - | - | - | - | [1] 11 11 💬
|